13F reference period
Q3 2026
Security Snapshot
ANI PHARMACEUTICALS INC - Common Stock (ANIP) Institutional Ownership
CUSIP: 00182C103
13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026
Institutions Reporting
159
Shares (Excl. Options)
9.91M
Full value: 9,911,941 · shares · 30 Sep 2026Price
$72.65
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- ANIP on Nasdaq
- All holders as of 30 Sep 2026
- Q3 2026
- Total 13F shares
- 9,911,941
- Total 13F value
- $714,769,307
- Portfolio coverage rank
- 0%
- Share change
- -313,716
- Value change
- -$36,139,888
- Number of holders
- 159
- Shares outstanding
- 22,655,023
- SEC-reported price per share
- $71.98
- Insider filing price
- $71.98
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- ANIP - ANI PHARMACEUTICALS INC - Common Stock is tracked under CUSIP 00182C103.
- 159 institutions reported positions in Q3 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 305 to 159 between Q2 2026 and Q3 2026.
- SEC-reported value moved from to
$1.9B
Full value: $1,900,274,830 · USD · 30 Jun 2026.$714.77M
Full value: $714,769,307 · USD · 30 Sep 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 159 institutions filings for Q3 2026.
Security key
00182C103
13F reference period
Q3 2026
13F holders
159
13D/G owners
4
CIK / CUSIP context first
Open Q3 2026 holders
ANIP full holder history
ANI PHARMACEUTICALS INC SEC filings
ANI PHARMACEUTICALS INC company facts
ANI PHARMACEUTICALS INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00182C103:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
ANIP
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13% | +14% | $240,049,004 | +$31,656,645 | 2,899,843 | +15% | BlackRock, Inc. | 30 Jun 2026 |
| Meridian Venture Partners II GP, L.P. | 4.8% | -12% | $66,419,394 | -$9,630,000 | 1,034,570 | -13% | Robert E. Brown, Jr. | 21 Aug 2025 |
| MILLENNIUM MANAGEMENT LLC | 3.8% | -28% | $57,136,569 | -$19,037,261 | 818,341 | -25% | Millennium Management LLC | 31 Mar 2025 |
| INTEGRATED CORE STRATEGIES (US) LLC | 0.3% | -98% | $5,976,442 | -$96,309,614 | 65,245 | -94% | Millennium Management LLC | 30 Sep 2025 |
As of 30 Sep 2026,
159
institutional investors reported holding
shares of
ANI PHARMACEUTICALS INC - Common Stock (ANIP).
This represents
44%
of the company’s total
outstanding shares.
9.91M
Full value: 9,911,941 · shares · 30 Sep 202622.66M
Full value: 22,655,023 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
38%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| STATE STREET CORP | 4.2% | 950,970 | +14% | 0% | $69,087,971 |
| AMERICAN CENTURY COMPANIES INC | 4% | 912,647 | +59% | 0.03% | $66,303,805 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 904,707 | +7.9% | 0% | $65,726,964 |
| DIMENSIONAL FUND ADVISORS LP | 3.2% | 728,748 | +17% | 0.01% | $52,943,139 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4% | 545,063 | +1.6% | 0% | $39,605,973 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.2% | 491,834 | -12% | 0.02% | $35,731,740 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.8% | 413,848 | +1.6% | 0% | $30,066,057 |
| DEUTSCHE BANK AG\ | 1.5% | 346,757 | +7.2% | 0.01% | $25,191,896 |
| Aberdeen Group plc | 1.5% | 334,350 | +23% | 0.03% | $24,290,528 |
| Invesco Ltd. | 1.4% | 325,243 | +5.2% | 0% | $23,628,904 |
| KENNEDY CAPITAL MANAGEMENT LLC | 1.3% | 301,287 | +1.8% | 0.41% | $21,888,501 |
| Ranger Investment Management, L.P. | 1.2% | 268,628 | -22% | 1.8% | $19,515,824 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.1% | 246,345 | -4.6% | 0.06% | $17,896,964 |
| MIZUHO MARKETS AMERICAS LLC | 1% | 230,260 | +9.8% | 0.27% | $16,728,389 |
| MORGAN STANLEY | 1% | 227,144 | +7.6% | 0% | $16,502,077 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 0.97% | 220,053 | +0.01% | 0.04% | $15,986,851 |
| Penn Capital Management Company, LLC | 0.94% | 213,246 | +2.8% | 1.1% | $15,515,026 |
| Ruffer LLP | 0.74% | 166,587 | +140% | 0.35% | $6,868,940 |
| VANGUARD FIDUCIARY TRUST CO | 0.64% | 144,332 | +8% | 0% | $10,485,720 |
| CSM Advisors, LLC | 0.58% | 130,804 | +30% | 0.2% | $9,501,000 |
| Dana Investment Advisors, Inc. | 0.57% | 129,783 | +18% | 0.25% | $9,428,735 |
| FIRST TRUST ADVISORS LP | 0.45% | 100,971 | +3.2% | 0% | $7,335,543 |
| BNP PARIBAS FINANCIAL MARKETS | 0.43% | 97,456 | 0% | $7,080,178 | |
| THOMPSON SIEGEL & WALMSLEY LLC | 0.41% | 93,691 | +1.1% | 0.13% | $6,807,000 |
| MARATHON CAPITAL MANAGEMENT | 0.32% | 71,810 | -0.25% | 1.1% | $5,216,997 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 9,911,941 | $714,769,307 | -$36,139,888 | $72.65 | 159 |
| 2026 Q2 | 22,949,932 | $1,900,274,830 | -$26,207,534 | $82.78 | 305 |
| 2026 Q1 | 23,380,486 | $1,797,284,723 | +$144,278,188 | $76.90 | 279 |
| 2025 Q4 | 21,151,784 | $1,669,959,225 | +$30,069,338 | $78.94 | 284 |
| 2025 Q3 | 20,389,328 | $1,867,651,983 | +$52,854,102 | $91.60 | 266 |
| 2025 Q2 | 19,725,780 | $1,287,090,849 | -$20,870,018 | $65.25 | 229 |
| 2025 Q1 | 19,963,692 | $1,336,584,283 | +$48,405,121 | $66.95 | 226 |
| 2024 Q4 | 19,278,460 | $1,065,666,126 | +$20,364,527 | $55.28 | 204 |
| 2024 Q3 | 18,878,833 | $1,126,182,384 | +$220,571,922 | $59.66 | 207 |
| 2024 Q2 | 15,122,528 | $963,007,127 | +$64,529,569 | $63.68 | 200 |
| 2024 Q1 | 14,090,492 | $974,037,268 | +$37,316,448 | $69.13 | 195 |
| 2023 Q4 | 13,616,342 | $750,788,600 | +$15,033,397 | $55.14 | 180 |
| 2023 Q3 | 13,199,659 | $766,379,240 | +$52,240,515 | $58.06 | 184 |
| 2023 Q2 | 12,299,725 | $662,081,429 | +$105,431,062 | $53.83 | 169 |
| 2023 Q1 | 10,365,411 | $411,702,884 | +$7,764,406 | $39.72 | 137 |
| 2022 Q4 | 10,254,354 | $412,610,775 | +$2,387,720 | $40.23 | 125 |
| 2022 Q3 | 10,269,268 | $330,253,290 | +$12,871,843 | $32.14 | 115 |
| 2022 Q2 | 9,879,095 | $293,397,646 | +$29,894,218 | $29.67 | 109 |
| 2022 Q1 | 9,205,000 | $258,822,043 | -$5,750,270 | $28.11 | 115 |
| 2021 Q4 | 8,972,675 | $413,375,358 | +$78,226,286 | $46.08 | 126 |
| 2021 Q3 | 7,280,546 | $238,830,760 | +$14,353,157 | $32.82 | 105 |
| 2021 Q2 | 7,204,407 | $252,488,638 | -$2,871,513 | $35.05 | 104 |
| 2021 Q1 | 7,293,016 | $263,483,493 | +$391,549 | $36.14 | 100 |
| 2020 Q4 | 7,361,043 | $213,798,867 | +$1,986,104 | $29.04 | 109 |
| 2020 Q3 | 7,312,777 | $206,302,713 | -$6,295,496 | $28.21 | 105 |